Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Guardado en:
Autores principales: | Meletios A. Dimopoulos, Philippe Moreau, Evangelos Terpos, María-Victoria Mateos, Sonja Zweegman, Gordon Cook, Michel Delforge, Roman Hájek, Fredrik Schjesvold, Michele Cavo, Hartmut Goldschmidt, Thierry Facon, Hermann Einsele, Mario Boccadoro, Jesús San-Miguel, Pieter Sonneveld, Ulrich Mey, on behalf of the EHA Guidelines Committee and the ESMO Guidelines Committee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c1865baaad2e4205a7ac4ccb6e05bd2a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The EHA Research Roadmap: Normal Hematopoiesis
por: Thierry Jaffredo, et al.
Publicado: (2021) -
Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
por: Achille Iolascon, et al.
Publicado: (2021) -
Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
por: Foteini Theodorakakou, et al.
Publicado: (2021) -
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS
por: Mehmut TURGUT, et al.
Publicado: (2021) -
The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Julio Delgado, et al.
Publicado: (2021)